Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Powering mesoporous silica nanoparticles into bioactive nanoplatforms for antibacterial therapies: strategies and challenges

Fig. 6

Reproduced with permission from Ref. [140] Copyright 2021, American Chemical Society. C Illustration of the design of a bionic nano-delivery system for the treatment of bacterial infections. D The inhibition of E. coli by Rif, Rif@MSN, and Rif@OMV@MSN nanoparticles. Reproduced with permission from Ref. [142] Copyright 2021, Wiley–VCH GmbH. E The construction and targeting of HOMSN-Tre-INH nanosystems to bacteria. Reproduced with permission from Ref. [143] Copyright 2015, WILEY–VCH. F Illustration of the specific inhibition of L. monocytogenes by BAC loaded mesoporous silica nanoparticles. Reproduced with permission from Ref. [145] Copyright 2021, Elsevier B.V

A The preparation process of Ag@MSN-QPEI nanoparticles and the mechanism of electrostatic adhesion to bacteria. B The antibacterial effects of QPEI, Ag@MSN and Ag@MSN-QPEI at 10, 20 and 40 mg/L concentrations against P. syringae pv. lachrymans.

Back to article page